Course curriculum

    1. Acute bacterial prostatitis (March 2021)

    2. Acute bacterial sinusitis - 2Qs (March 2023)

    3. Acute bronchitis (September 2022)

    4. Acute epiglottitis (November 2022)

    5. Anosmia - 2Qs (May 2022)

    6. Antibiotic interactions - 3Qs (September 2018)

    7. Asymptomatic bacteriuria - 2Qs (November 2020)

    8. Autoimmune hepatitis (January 2019)

    9. Bacterial vaginosis (May 2021)

    10. Bat exposure (November 2019)

    11. Blepharitis (January 2023)

    12. Blood transfusions and COVID (March 2022)

    13. Breastfeeding contraindications - 2Qs (January 2023)

    14. Cat scratch disease (September 2019)

    15. Cervical cancer screening - 2Qs (September 2018)

    16. Chagas disease - 2Qs (March 2019)

    17. Chlamydia in the newborn (January 2020)

    18. Chlamydia trachomatis infection - 3Qs (January 2022)

    19. Choosing Wisely (March 2023)

    20. Chorioamnionitis (September 2021)

    21. Clinical decision-making - febrile illness -9Qs (March 2023)

    22. Clostridioides difficile infection (September 2023)

    23. Clostridioides difficile - 3Qs (November 2021)

    24. Clostridium difficile in children (November 2018)

    25. Clostridium difficile - overview - 2Qs (November 2018)

    26. Clostridium difficile - treatment -2Qs (September 2018)

    27. Common cold - Prevention (September 2018)

    28. Common cold - treatment (January 2022)

    29. Common cold - treatment (September 2022)

    30. Common variable immunodeficiency (March 2022)

    31. Community-acquired pneumonia - 2Qs (March 2022)

    32. Community-acquired pneumonia in adults - outpatient - 2Qs (January 2020)

    33. Community acquired pneumonia in children - 2Qs (January 2023)

    34. Community-acquired pneumonia - inpatient - 2Qs (January 2020)

    35. Complications after splenectomy (March 2022)

    36. Coronavirus - 2Qs (March 2020)

    37. Condyloma acuminata - 2Qs (November 2018)

    38. Condyloma acuminata in pregnancy (July 2022)

    39. Condyloma acuminata - treatment - 2Qs (July 2022) - UPDATED

    40. Congenital syphilis - 3Qs (January 2023)

    41. Cough - postinfectious (January 2019)

    42. COVID - oral treatment - 2Qs (September 2023)

    43. COVID-19 - oral treatment (May 2022)

    44. Coxsackievirus (November 2018)

    45. Croup - 2Qs (January 2023)

    46. Cytomegalovirus - 2Qs (May 2021)

    47. Dengue - 2Qs (May 2023)

    48. Dengue - 2Qs (July 2020)

    49. Dermatologic manifestations of COVID-19 - 3Qs (September 2020)

    50. Diabetic foot osteomyelitis - 3Qs (May 2020)

    51. Disseminated gonococcal infection - 2Qs (November 2021)

    52. Diverticulitis - 4Qs (January 2022)

    53. Dog and cat bites - 3Qs (May 2019)

    54. Dyspepsia - 2Qs (September 2021)

    55. Dysphonia - 3Qs (May 2022)

    56. Ebola - 3Qs (January 2022)

    57. Ehrlichiosis - 2Qs (May 2022)

    58. Endocarditis prophylaxis (January 2023)

    59. Enteric fever (Typhoid and Paratyphoid) - 2Qs (November 2020)

    60. Enterovirus D68 (May 2020)

    61. Eosinophilia - 2Qs (May 2020)

    62. Epididymitis - 3Qs (May 2021)

    63. Erysipelas (September 2021)

    64. Esophageal disorders - 3Qs (November 2019)

    65. Extrapulmonary tuberculosis - 3Qs (November 2022)

    66. Fluoroquinolones - adverse effects (July 2019)

    67. Fluoroquinolones - adverse effects - 2Qs (November 2018)

    68. Food poisoning - 5Qs (July 2020)

    69. Gastric cancer (July 2022)

    70. Gastroenteritis - Pediatric - 3Qs (May 2020)

    71. Gastroparesis - 3Qs (January 2023)

    72. Gonorrhea - 3Qs (November 2021)

    73. Group B strep - early onset disease - 2Qs (January 2020)

    74. Group B strep - late onset disease (January 2020)

    75. Group B strep screening and prophylaxis - 3Qs (January 2020)

    76. H. pylori - diagnosis - 2Qs (July 2022)

    77. Handwashing (November 2021)

    78. Handwashing (May 2019)

    79. Head lice (March 2022)

    80. Head lice (September 2019)

    81. Helicobacter pylori - 2Qs (November 2019)

    82. Hematospermia - 2Qs (May 2020)

    83. Hepatitis A pre- and post-exposure prophylaxis - 2Qs (January 2021)

    84. Hepatitis A - 2Qs (May 2020)

    85. Hepatitis A - pre- and post-exposure prophylaxis - 2Qs (March 2019)

    86. Hepatitis A vaccination - 2Qs (March 2019)

    87. Hepatitis B virus screening and vaccination - 2Qs (July 2018)

    88. Hepatitis C exposure and healthcare personnel (January 2021)

    89. Hepatitis C and renal disease - 2Qs (September 2022)

    90. Hepatitis C - screening - 2Qs (July 2020)

    91. Hepatitis C testing in pregnancy - 3Qs (July 2020)

    92. Hepatitis C treatment - 2Qs (January 2021)

    93. Hepatitis E - 2Qs (May 2022)

    94. Herpes in pregnancy (March 2019)

    95. Herpes simplex virus (HSV) in pregnancy - 3Qs (September 2020)

    96. Herpes zoster - 2Qs (November 2022)

    97. Herpes zoster opthalmicus (September 2021)

    98. Herpetic Esophagitis - 3Qs (November 2019)

    99. Herpes simplex infection and pregnancy - 2Qs (January 2023)

    100. Herpes zoster - 3Qs (November 2021)

    101. Herpes zoster -2Qs (November 2018)

    102. High-grade cervical squamous intraepithelial lesion (July 2018)

    103. HIV and breastfeeding (March 2020)

    104. HIV and cardiovascular disease -2Qs (January 2020)

    105. HIV during pregnancy and in infants - 2Qs (March 2020)

    106. HIV in older adults (March 2020)

    107. HIV screening (November 2021)

    108. Hot tub folliculitis (September 2020)

    109. HPV infection counseling (July 2022)

    110. HPV-related cancers - 3Qs (November 2021)

    111. HPV - Vaccines and Indications - 2Qs (November 2020)

    112. Human bites (May 2021)

    113. Human bite injuries - 2Qs (July 2019)

    114. Human metapneumovirus (January 2020)

    115. Human papilloma virus vaccine update - 3Qs (March 2019)

    116. Immunizations and adults with HIV - 2Qs (September 2019)

    117. Immunizations and children with HIV (September 2019)

    118. Infants and HIV exposure - 2Qs (March 2020)

    119. Infections and cardiovascular disease -2Qs (January 2021)

    120. Infection of cardiac implantable electronic devices - 2Qs (January 2023)

    121. Infectious mononucleosis (January 2022)

    122. Infectious mononucleosis (January 2020)

    123. Influenza diagnosis (July 2019)

    124. Influenza in high risk populations - 3Qs (May 2020)

    125. Influenza in long-term care facilities - 2Qs (May 2020)

    126. Influenza prevention (March 2022)

    127. Influenza - prevention and treatment (November 2022)

    128. Influenza testing (March 2022)

    129. Influenza treatment and prophylaxis - 2Qs (March 2022)

    130. Interferon gamma release assay for TB - 3Qs (September 2020)

    131. Invasive meningococcal disease - chemoprophylaxis (November 2018)

    132. Latent syphilis - 2Qs (November 2021)

    133. Latent tuberculosis - 2Qs (March 2019)

    134. Legionella - 2Qs (November 2020)

    135. Leptospirosis (July 2020)

    136. Leptospirosis (March 2019)

    137. Lung abscess (September 2022)

    138. Lyme disease - 2Qs (May 2021)

    139. Lyme disease - cutaneous - 2Qs (May 2021)

    140. Lyme - Noncutaneous - 3Qs (May 2021)

    141. Malaria - diagnosis (May 2022)

    142. Malaria prophylaxis - 2Qs (March 2022)

    143. Management of neonates exposed to HSV - 2Qs (September 2020)

    144. Measles (September 2020)

    145. Measles - 2Qs (November 2018)

    146. Meningococcal ACWY vaccines - 2Qs (November 2018)

    147. Meningococcal type B vaccine (November 2018)

    148. Molluscum contagiosum - 2Qs (March 2019)

    149. Monkeypox - 4Qs (September 2023)

    150. Mycobacterium Avium Complex - 2Qs (July 2019)

    151. Myocarditis - 2Qs (March 2021)

    152. Necrotizing soft tissue infection (March 2022)

    153. Needlestick injuries - 3Qs (November 2021)

    154. Neonatal gonococcal infection (November 2021)

    155. Neonatal herpes simplex virus (HSV) -2Qs (September 2020)

    156. Neonatal sepsis (July 2021)

    157. Neuraminidase inhibitors for influenza -3Qs (May 2023)

    158. Orbital cellulitis - 2Qs (September 2022)

    159. Orbital cellulitis - 2Qs (July 2021)

    160. Oropharyngeal Candidiasis (July 2019)

    161. Osteomyelitis - 3Qs (May 2019)

    162. Pediatric limp - 3Qs (January 2019)

    163. Pelvic inflammatory disease - 3Qs (March 2022)

    164. Pelvic inflammatory disease - 3Qs (November 2021)

    165. Pericarditis - Acute - 2Qs (September 2018)

    166. Perinatal Group B Streptococcus - prevention - 3Qs (November 2018)

    167. Pertussis - 4Qs (January 2021)

    168. Pilonidal disease - 2Qs (September 2022)

    169. Pneumococcal disease - Prevention (July 2022)

    170. Pneumonia - atypical- 2 Qs (January 2023)

    171. Post COVID syndrome - 4Qs (November 2022)

    172. Post-infectious cough (November 2022)

    173. Postoperative fever - 2Qs (January 2021)

    174. Post-streptococcal glomerulonephritis - 2Qs (November 2021)

    175. Preexposure prophylaxis in pregnancy (PrEP) (September 2019)

    176. Preventing IV catheter infection - 2Qs (January 2022)

    177. Prostatitis - 3Qs (July 2019)

    178. Ramsay Hunt syndrome (November 2021)

    179. Ramsay Hunt syndrome - 2Qs (March 2023)

    180. Reactive arthritis (March 2020)

    181. Refugee care (July 2019)

    182. Respiratory Syncytial Virus - 2Qs (September 2019)

    183. Rheumatic fever - acute - 3Qs (March 2022)

    184. Rotavirus (July 2022)

    185. Salmonella infection (September 2019)

    186. Scalp lesions - 5Qs (September 2018)

    187. Scarlet fever (March 2019)

    188. Schistosomiasis - 2Qs (January 2020)

    189. Screening for sexually transmitted infections - 4Qs (July 2022)

    190. Sinusitis - complications (November 2019)

    191. Soft Tissue Infections - 9 Qs (September 2022)

    192. Spontaneous bacterial peritonitis - 2Qs (March 2020)

    193. Streptococcal pharyngitis in children (November 2020)

    194. Surgical site infections (March 2023)

    195. Syphilis - 3Qs (September 2019)

    196. Syphilis - Congenital - 3Qs (September 2018)

    197. Syphilis in pregnancy - 2Qs (January 2022)

    198. Syphilis testing - 4Qs (March 2022)

    199. Tertiary syphilis - 2Qs (January 2022)

    200. Tick paralysis (November 2020)

    201. Travel and polio - 2Qs (January 2020)

    202. Trichomoniasis - 2Qs (March 2022)

    203. Trichomoniasis (March 2020)

    204. Tuberculosis - extrapulmonary - 3Qs (January 2019)

    205. Tuberculosis in pregnancy (March 2019)

    206. Tuberculosis - latent infection - 2Qs (May 2020)

    207. Tuberculosis testing - 2Qs (September 2018)

    208. Tularemia - 2Qs (September 2019)

    209. Upper respiratory tract infection - treatment - 2Qs (January 2021)

    210. Urethritis (July 2022)

    211. UTI in children (March 2021)

    212. Varicella zoster vaccine (March 2023)

    213. Vulvovaginal candidiasis in pregnancy (UPDATED) (September 2019)

    214. Vulvovaginal Candidiasis in pregnancy (September 2018)

    215. Yellow fever (March 2023)

    216. Yellow fever - 2Qs (September 2019)

    217. Zika infection (January 2019)

    218. Zika syndrome - Congenital (January 2019)

About this course

  • Free
  • 218 lessons
  • 0 hours of video content